Literature DB >> 16465401

Fructokinase activity in rat liver, ileum, parotid gland, pancreas, pancreatic islet, B and non-B islet cell homogenates.

Marie-Helene Giroix1, Hassan Jijakli, Philippe Courtois, Ying Zhang, Abdullah Sener, Willy J Malaisse.   

Abstract

The presence of fructokinase (ketohexokinase) in rat pancreatic islet homogenates was previously documented. However, no information was so far available on the activity of this enzyme in islets relative to that in other tissues and on the respective contribution of insulin-producing B cells and non-B islet cells. The present study provides such an information. The activity of fructokinase, as assessed by the phosphorylation of 1.0 mM D-fructose, was compared to that of hexokinase isoenzyme(s), as measured in the presence of 1.0 mM D-glucose, and further characterized by its heat-resistance, K+ dependency and resistance to the inhibitory action of D-mannoheptulose. As judged from the results obtained in heated homogenates, the activity of fructokinase, expressed relative to protein content (nmol/min per mg protein) was highest in liver (21.5 +/- 2.5; n = 11) and lowest in parotid gland (0.16 +/- 0.09; n = 3), with in-between values in ileum (2.45 +/- 0.53; n = 3), pancreas (0.82 +/- 0.11; n = 11) and pancreatic islets (0.46 +/- 0.07; n = 6). The paired ratio between fructokinase and hexokinase isoenzyme activity was also highest in liver (548 +/- 45%; n = 8) and lowest in parotid gland (0.93 +/- 0.52%; n = 3). Such a ratio was not significantly different in pancreas, islets and purified B or non-B islet cells, with an overall mean value of 2.57 +/- 0.46% (n = 12). The present findings thus unambiguously document the presence of fructokinase activity in all cell types under consideration, except possibly parotid cells, with the following hierarchy: liver > ileum > pancreas. Relative to paired hexokinase activity, no obvious difference was found for fructokinase activity in B versus non-B islet cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16465401

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  5 in total

1.  Does NAD(P)H oxidase-derived H2O2 participate in hypotonicity-induced insulin release by activating VRAC in β-cells?

Authors:  R Crutzen; V Shlyonsky; K Louchami; M Virreira; E Hupkens; A Boom; A Sener; W J Malaisse; R Beauwens
Journal:  Pflugers Arch       Date:  2011-11-18       Impact factor: 3.657

Review 2.  The role of fructose transporters in diseases linked to excessive fructose intake.

Authors:  Veronique Douard; Ronaldo P Ferraris
Journal:  J Physiol       Date:  2012-11-05       Impact factor: 5.182

3.  Ketohexokinase: expression and localization of the principal fructose-metabolizing enzyme.

Authors:  Christine P Diggle; Michael Shires; Derek Leitch; David Brooke; Ian M Carr; Alex F Markham; Bruce E Hayward; Aruna Asipu; David T Bonthron
Journal:  J Histochem Cytochem       Date:  2009-04-13       Impact factor: 2.479

4.  Excessive Intake of High-Fructose Corn Syrup Drinks Induces Impaired Glucose Tolerance.

Authors:  Hidemi Hattori; Yuma Hanai; Yuto Oshima; Hiroaki Kataoka; Nozomu Eto
Journal:  Biomedicines       Date:  2021-05-12

Review 5.  Intestinal Fructose and Glucose Metabolism in Health and Disease.

Authors:  Beatriz Merino; Cristina M Fernández-Díaz; Irene Cózar-Castellano; German Perdomo
Journal:  Nutrients       Date:  2019-12-29       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.